ARTICLE | Clinical News
Human heterologous liver cells regulatory update
October 25, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Cytonet's human heterologous liver cells to treat hyperargininemia, argininosuccinic aciduria, citrullinemia type 1 and carbamoy...